Non-isotopic method for estimating erythrocyte mean age using erythrocyte creatine

使用红细胞肌酸估算红细胞平均年龄的非同位素方法

基本信息

  • 批准号:
    12672245
  • 负责人:
  • 金额:
    $ 1.98万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Erythrocyte creatine is a sensitive marker of erythrocyte age, and can be used to detect slight and continuous hemolysis. Excessive blood cell destruction caused by increased spleen function is important evidence of hypersplenism. We evaluated the usefulness of erythrocyte creatine as a marker of excessive erythrocyte destruction in patients with liver cirrhosis. The patients with splenomegaly showed significantly higher erythrocyte creatine than those without splenomegaly and healthy controls, but there was no significant difference in erythrocyte creatine between healthy controls and those without splenomegaly. Fourteen of the 15 patients with abnormally high erythrocyte creatine had splenomegaly. There were no significant differences in reticulocyte count between healthy controls and the patients with and without splenomegaly. Erythrocyte creatine showed good correlation with spleen size. Thus, erythrocyte creatine can be used for estimating hypersplenism in patients with liver cirr … More hosis.Cardiac vale replacement with mechanical prosthesis is associated with mild intravascular hemolysis. To estimate the intravascular hemolysis due to cardiac valve dysfunction, we analyzed erythrocyte creatine in 32 patients with prosthetic mitral and/or aortic valve, and the data were compared with cardiac valve flow dynamics. No significant differences in erythrocyte creatine and other hemolytic markers including serum lactic dehydrogenase, haptoglobin, indirect bilirubin and reticulocyte counts were observed between the patients in the presence and absence of regurgitations. Although erythrocyte creatine, serum lactic dehydrogenase and haptoglobin in the patients with prosthetic valve showed significant differences as compared to those in healthy controls, total peak transvalvular flow velocities (peak transmitral flow velocity + peak transaortic flow velocity) had significant correlation with only erythrocyte creatine. These results suggest that the intravascular hemolysis is attributed chiefly to transvalvular flow velocity rather than regurgitation in patients with mechanical valve prosthesis, and hence erythrocyte creatine is a possible marker for assessment of cardiac valve dysfunction. Less
红细胞肌酸是反映红细胞年龄的敏感指标,可用于检测轻度和持续性溶血。脾功能增强引起的血细胞过度破坏是脾功能亢进的重要证据。我们评估了红细胞肌酸作为肝硬化患者红细胞过度破坏的标志物的有用性。脾肿大组红细胞肌酸水平显著高于非脾肿大组和健康对照组,而健康对照组与非脾肿大组红细胞肌酸水平无显著性差异。15例红细胞肌酸异常增高的患者中有14例有脾肿大。网织红细胞计数在健康对照组与脾肿大组和非脾肿大组之间无显著差异。红细胞肌酸与脾脏大小呈良好的相关性。因此,红细胞肌酸可用于评估肝硬化患者的脾功能亢进, ...更多信息 机械瓣膜置换术与轻度血管内溶血有关。为评价心脏瓣膜功能障碍引起的血管内溶血,对32例二尖瓣和(或)主动脉瓣置换术患者的红细胞肌酸进行了测定,并与心脏瓣膜血流动力学进行了比较。红细胞肌酸和其他溶血标志物,包括血清乳酸脱氢酶,结合珠蛋白,间接胆红素和网织红细胞计数之间没有显着差异,观察患者的存在和不存在的过敏。尽管人工瓣膜患者的红细胞肌酸、血清乳酸脱氢酶和结合珠蛋白与健康对照组相比存在显著差异,但总跨瓣峰值流速(二尖瓣峰值流速+主动脉峰值流速)仅与红细胞肌酸显著相关。这些结果表明,血管内溶血的主要原因是跨瓣血流速度,而不是反流在机械瓣患者,因此,红细胞肌酸是一个可能的指标,以评估心脏瓣膜功能障碍。少

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yoshiaki Takemoto, et al.: "Erythrocyte creatine as an index of the erythrocyte life span and erythropoiesis"Nephron. 86. 513-514 (2000)
Yoshiaki Takemoto 等人:“红细胞肌酸作为红细胞寿命和红细胞生成的指标”肾单位。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yu-Fei Jiao, et al.: "Erythrocyte creatine as a marker of excessive erythrocyte destruction due to hypersplenism in patients with liver cirrhosis"Clinical Biochemistry. 34. 395-398 (2001)
Yu-Fei Jiao 等人:“红细胞肌酸作为肝硬化患者脾功能亢进导致红细胞过度破坏的标志物”《临床生物化学》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Jiao Y-F, Okumiya T, Saibara T, Kudo Y, Sugiura T: "Erythrocyte creatine as a marker of excessive erythrocyte destruction due to hypersplenism in patients with liver cirrhosis"Clin Biochem. 34. 395-398 (2001)
Jiao Y-F、Okumiya T、Saibara T、Kudo Y、Sugiura T:“红细胞肌酸作为肝硬化患者脾功能亢进导致红细胞过度破坏的标志物”Clin Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OKUMIYA Toshika其他文献

OKUMIYA Toshika的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OKUMIYA Toshika', 18)}}的其他基金

Establishment of newborn screening and molecular basis of chemical chaperone therapy for glycogen storage disease II
糖原贮积病新生儿筛查及化学伴侣疗法分子基础的建立II
  • 批准号:
    19590563
  • 财政年份:
    2007
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular basis of lysosomal storage disease and the possibility of a new therapeutic approach
溶酶体贮积病的分子基础和新治疗方法的可能性
  • 批准号:
    10672178
  • 财政年份:
    1998
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The role of protein glycosylation in erythropoiesis
蛋白质糖基化在红细胞生成中的作用
  • 批准号:
    DP240100832
  • 财政年份:
    2024
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Discovery Projects
Deciphering the molecular mechanism of ineffective erythropoiesis in MDS-5q
破译MDS-5q无效红细胞生成的分子机制
  • 批准号:
    10773217
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Regulation of erythroid iron metabolism by the CLPX unfoldase
CLPX 解折叠酶对红细胞铁代谢的调节
  • 批准号:
    10716494
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Transcriptional Control During Erythropoiesis
红细胞生成过程中的转录控制
  • 批准号:
    10892619
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Carbohydrate-Mediated Platelet Clearance
碳水化合物介导的血小板清除
  • 批准号:
    10608645
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Elucidating the mechanism of erythropoiesis through the search for transcription factors targeted by deubiquitinating enzyme X.
通过寻找去泛素化酶 X 靶向的转录因子来阐明红细胞生成机制。
  • 批准号:
    23K15310
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Cell-extrinsic emergency myelopoiesis regulated by ABCB7
ABCB7 调控的细胞外紧急骨髓细胞生成
  • 批准号:
    10675321
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Specificity of RPSA-dependent translational control in mouse and human fetal spleen cells
小鼠和人胎儿脾细胞中 RPSA 依赖性翻译控制的特异性
  • 批准号:
    10647605
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion. Project 3
红细胞输注同种免疫的基本和转化机制。
  • 批准号:
    10711670
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Investigating PUM1 mediated post-transcriptional regulation of human hemoglobin switching and erythropoiesis
研究 PUM1 介导的人血红蛋白转换和红细胞生成的转录后调节
  • 批准号:
    10568059
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了